Golumbeski George
SEC-identified person · CIK 1586660 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Acumen Pharmaceuticals, Inc. ABOS | Director | filed 2025–2026 |
| Shattuck Labs, Inc. STTK | Director | filed 2020–2026 |
| Mural Oncology plc MURA US | Director | filed 2024–2025 |
| Sage Therapeutics, Inc. SAGE | Director | filed 2019–2025 |
| Corbus Pharmaceuticals Holdings, Inc. CRBP | Director | filed 2020–2020 |
| Enanta Pharmaceuticals INC ENTA | Director | filed 2014–2020 |
| Acceleron Pharma INC XLRN | Director | filed 2013–2013 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.